ID   B4GN1_HUMAN             Reviewed;         533 AA.
AC   Q00973; B4DE26; Q8N636;
DT   01-JUN-1994, integrated into UniProtKB/Swiss-Prot.
DT   01-NOV-1995, sequence version 2.
DT   10-MAY-2017, entry version 161.
DE   RecName: Full=Beta-1,4 N-acetylgalactosaminyltransferase 1;
DE            EC=2.4.1.92 {ECO:0000269|PubMed:1601877};
DE   AltName: Full=(N-acetylneuraminyl)-galactosylglucosylceramide;
DE   AltName: Full=GM2/GD2 synthase;
DE   AltName: Full=GalNAc-T;
GN   Name=B4GALNT1; Synonyms=GALGT, SIAT2;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), FUNCTION, CATALYTIC ACTIVITY,
RP   AND PATHWAY.
RX   PubMed=1601877;
RA   Nagata Y., Yamashiro S., Yodoi J., Lloyd K.O., Shiku H., Furukawa K.;
RT   "Expression cloning of beta 1,4 N-acetylgalactosaminyltransferase
RT   cDNAs that determine the expression of GM2 and GD2 gangliosides.";
RL   J. Biol. Chem. 267:12082-12089(1992).
RN   [2]
RP   SEQUENCE REVISION TO 412-533.
RX   PubMed=8120069;
RA   Nagata Y., Yamashiro S., Yodoi J., Lloyd K.O., Shiku H., Furukawa K.;
RT   "Expression cloning of beta 1,4 N-acetylgalactosaminyltransferase
RT   cDNAs that determine the expression of GM2 and GD2 gangliosides.";
RL   J. Biol. Chem. 269:7045-7045(1994).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 2).
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=16541075; DOI=10.1038/nature04569;
RA   Scherer S.E., Muzny D.M., Buhay C.J., Chen R., Cree A., Ding Y.,
RA   Dugan-Rocha S., Gill R., Gunaratne P., Harris R.A., Hawes A.C.,
RA   Hernandez J., Hodgson A.V., Hume J., Jackson A., Khan Z.M.,
RA   Kovar-Smith C., Lewis L.R., Lozado R.J., Metzker M.L.,
RA   Milosavljevic A., Miner G.R., Montgomery K.T., Morgan M.B.,
RA   Nazareth L.V., Scott G., Sodergren E., Song X.-Z., Steffen D.,
RA   Lovering R.C., Wheeler D.A., Worley K.C., Yuan Y., Zhang Z.,
RA   Adams C.Q., Ansari-Lari M.A., Ayele M., Brown M.J., Chen G., Chen Z.,
RA   Clerc-Blankenburg K.P., Davis C., Delgado O., Dinh H.H., Draper H.,
RA   Gonzalez-Garay M.L., Havlak P., Jackson L.R., Jacob L.S., Kelly S.H.,
RA   Li L., Li Z., Liu J., Liu W., Lu J., Maheshwari M., Nguyen B.-V.,
RA   Okwuonu G.O., Pasternak S., Perez L.M., Plopper F.J.H., Santibanez J.,
RA   Shen H., Tabor P.E., Verduzco D., Waldron L., Wang Q., Williams G.A.,
RA   Zhang J., Zhou J., Allen C.C., Amin A.G., Anyalebechi V., Bailey M.,
RA   Barbaria J.A., Bimage K.E., Bryant N.P., Burch P.E., Burkett C.E.,
RA   Burrell K.L., Calderon E., Cardenas V., Carter K., Casias K.,
RA   Cavazos I., Cavazos S.R., Ceasar H., Chacko J., Chan S.N., Chavez D.,
RA   Christopoulos C., Chu J., Cockrell R., Cox C.D., Dang M.,
RA   Dathorne S.R., David R., Davis C.M., Davy-Carroll L., Deshazo D.R.,
RA   Donlin J.E., D'Souza L., Eaves K.A., Egan A., Emery-Cohen A.J.,
RA   Escotto M., Flagg N., Forbes L.D., Gabisi A.M., Garza M., Hamilton C.,
RA   Henderson N., Hernandez O., Hines S., Hogues M.E., Huang M.,
RA   Idlebird D.G., Johnson R., Jolivet A., Jones S., Kagan R., King L.M.,
RA   Leal B., Lebow H., Lee S., LeVan J.M., Lewis L.C., London P.,
RA   Lorensuhewa L.M., Loulseged H., Lovett D.A., Lucier A., Lucier R.L.,
RA   Ma J., Madu R.C., Mapua P., Martindale A.D., Martinez E., Massey E.,
RA   Mawhiney S., Meador M.G., Mendez S., Mercado C., Mercado I.C.,
RA   Merritt C.E., Miner Z.L., Minja E., Mitchell T., Mohabbat F.,
RA   Mohabbat K., Montgomery B., Moore N., Morris S., Munidasa M.,
RA   Ngo R.N., Nguyen N.B., Nickerson E., Nwaokelemeh O.O., Nwokenkwo S.,
RA   Obregon M., Oguh M., Oragunye N., Oviedo R.J., Parish B.J.,
RA   Parker D.N., Parrish J., Parks K.L., Paul H.A., Payton B.A., Perez A.,
RA   Perrin W., Pickens A., Primus E.L., Pu L.-L., Puazo M., Quiles M.M.,
RA   Quiroz J.B., Rabata D., Reeves K., Ruiz S.J., Shao H., Sisson I.,
RA   Sonaike T., Sorelle R.P., Sutton A.E., Svatek A.F., Svetz L.A.,
RA   Tamerisa K.S., Taylor T.R., Teague B., Thomas N., Thorn R.D.,
RA   Trejos Z.Y., Trevino B.K., Ukegbu O.N., Urban J.B., Vasquez L.I.,
RA   Vera V.A., Villasana D.M., Wang L., Ward-Moore S., Warren J.T.,
RA   Wei X., White F., Williamson A.L., Wleczyk R., Wooden H.S.,
RA   Wooden S.H., Yen J., Yoon L., Yoon V., Zorrilla S.E., Nelson D.,
RA   Kucherlapati R., Weinstock G., Gibbs R.A.;
RT   "The finished DNA sequence of human chromosome 12.";
RL   Nature 440:346-351(2006).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 3).
RC   TISSUE=Brain;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [6]
RP   DISULFIDE BONDS.
RX   PubMed=11018043; DOI=10.1074/jbc.M007480200;
RA   Li J., Yen T.Y., Allende M.L., Joshi R.K., Cai J., Pierce W.M.,
RA   Jaskiewicz E., Darling D.S., Macher B.A., Young W.W. Jr.;
RT   "Disulfide bonds of GM2 synthase homodimers. Antiparallel orientation
RT   of the catalytic domains.";
RL   J. Biol. Chem. 275:41476-41486(2000).
RN   [7]
RP   VARIANTS SPG26 CYS-300 AND ALA-433.
RX   PubMed=23746551; DOI=10.1016/j.ajhg.2013.05.006;
RA   Boukhris A., Schule R., Loureiro J.L., Lourenco C.M., Mundwiller E.,
RA   Gonzalez M.A., Charles P., Gauthier J., Rekik I.,
RA   Acosta Lebrigio R.F., Gaussen M., Speziani F., Ferbert A., Feki I.,
RA   Caballero-Oteyza A., Dionne-Laporte A., Amri M., Noreau A.,
RA   Forlani S., Cruz V.T., Mochel F., Coutinho P., Dion P., Mhiri C.,
RA   Schols L., Pouget J., Darios F., Rouleau G.A., Marques W. Jr.,
RA   Brice A., Durr A., Zuchner S., Stevanin G.;
RT   "Alteration of ganglioside biosynthesis responsible for complex
RT   hereditary spastic paraplegia.";
RL   Am. J. Hum. Genet. 93:118-123(2013).
CC   -!- FUNCTION: Involved in the biosynthesis of gangliosides GM2, GD2
CC       and GA2. {ECO:0000269|PubMed:1601877}.
CC   -!- CATALYTIC ACTIVITY: UDP-N-acetyl-alpha-D-galactosamine + O-(N-
CC       acetyl-alpha-neuraminyl)-(2->3)-O-beta-D-galactopyranosyl-(1->4)-
CC       beta-D-glucopyranosyl-(1<->1)-ceramide = UDP + O-2-(acetylamino)-
CC       2-deoxy-beta-D-galactopyranosyl-(1->4)-O-(N-acetyl-alpha-
CC       neuraminyl-(2->3))-O-beta-D-galactopyranosyl-(1->4)-beta-D-
CC       glucopyranosyl-(1<->1)-ceramide. {ECO:0000269|PubMed:1601877}.
CC   -!- PATHWAY: Sphingolipid metabolism. {ECO:0000269|PubMed:1601877}.
CC   -!- SUBUNIT: Homodimer; disulfide-linked.
CC       {ECO:0000269|PubMed:11018043}.
CC   -!- SUBCELLULAR LOCATION: Golgi apparatus membrane; Single-pass type
CC       II membrane protein.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=3;
CC       Name=1;
CC         IsoId=Q00973-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=Q00973-2; Sequence=VSP_055039;
CC       Name=3;
CC         IsoId=Q00973-3; Sequence=VSP_055040, VSP_055041;
CC   -!- DISEASE: Spastic paraplegia 26, autosomal recessive (SPG26)
CC       [MIM:609195]: A form of spastic paraplegia, a neurodegenerative
CC       disorder characterized by a slow, gradual, progressive weakness
CC       and spasticity of the lower limbs. Rate of progression and the
CC       severity of symptoms are quite variable. Initial symptoms may
CC       include difficulty with balance, weakness and stiffness in the
CC       legs, muscle spasms, and dragging the toes when walking. In some
CC       forms of the disorder, bladder symptoms (such as incontinence) may
CC       appear, or the weakness and stiffness may spread to other parts of
CC       the body. SPG26 is a complicated form characterized by onset in
CC       the first 2 decades of life of gait abnormalities due to lower
CC       limb spasticity and muscle weakness. Some patients have upper limb
CC       involvement. Additional features include intellectual disability,
CC       peripheral neuropathy, dysarthria, cerebellar signs,
CC       extrapyramidal signs, and cortical atrophy. The disorder is slowly
CC       progressive. {ECO:0000269|PubMed:23746551}. Note=The disease is
CC       caused by mutations affecting the gene represented in this entry.
CC   -!- SIMILARITY: Belongs to the glycosyltransferase 2 family.
CC       {ECO:0000305}.
CC   -!- WEB RESOURCE: Name=Functional Glycomics Gateway - GTase;
CC       Note=Beta-1,4 N-acetylgalactosaminyltransferase 1;
CC       URL="http://www.functionalglycomics.org/glycomics/molecule/jsp/glycoEnzyme/viewGlycoEnzyme.jsp?gbpId=gt_hum_480";
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; M83651; AAA35516.1; -; mRNA.
DR   EMBL; AK293432; BAG56937.1; -; mRNA.
DR   EMBL; AC025165; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; BC029828; AAH29828.1; -; mRNA.
DR   CCDS; CCDS61170.1; -. [Q00973-2]
DR   CCDS; CCDS61171.1; -. [Q00973-3]
DR   CCDS; CCDS8950.1; -. [Q00973-1]
DR   PIR; A44128; A44128.
DR   PIR; A54379; A54379.
DR   RefSeq; NP_001263397.1; NM_001276468.1. [Q00973-2]
DR   RefSeq; NP_001263398.1; NM_001276469.1. [Q00973-3]
DR   RefSeq; NP_001469.1; NM_001478.4. [Q00973-1]
DR   RefSeq; XP_016874631.1; XM_017019142.1. [Q00973-1]
DR   UniGene; Hs.159481; -.
DR   ProteinModelPortal; Q00973; -.
DR   BioGrid; 108856; 6.
DR   STRING; 9606.ENSP00000341562; -.
DR   SwissLipids; SLP:000000771; -.
DR   SwissLipids; SLP:000001406; -.
DR   CAZy; GT12; Glycosyltransferase Family 12.
DR   iPTMnet; Q00973; -.
DR   PhosphoSitePlus; Q00973; -.
DR   DMDM; 1168736; -.
DR   MaxQB; Q00973; -.
DR   PaxDb; Q00973; -.
DR   PeptideAtlas; Q00973; -.
DR   PRIDE; Q00973; -.
DR   DNASU; 2583; -.
DR   Ensembl; ENST00000341156; ENSP00000341562; ENSG00000135454. [Q00973-1]
DR   Ensembl; ENST00000418555; ENSP00000401601; ENSG00000135454. [Q00973-2]
DR   Ensembl; ENST00000550764; ENSP00000450303; ENSG00000135454. [Q00973-3]
DR   Ensembl; ENST00000552350; ENSP00000448500; ENSG00000135454. [Q00973-3]
DR   GeneID; 2583; -.
DR   KEGG; hsa:2583; -.
DR   UCSC; uc001spg.3; human. [Q00973-1]
DR   CTD; 2583; -.
DR   DisGeNET; 2583; -.
DR   GeneCards; B4GALNT1; -.
DR   HGNC; HGNC:4117; B4GALNT1.
DR   HPA; HPA008968; -.
DR   HPA; HPA015128; -.
DR   MalaCards; B4GALNT1; -.
DR   MIM; 601873; gene.
DR   MIM; 609195; phenotype.
DR   neXtProt; NX_Q00973; -.
DR   OpenTargets; ENSG00000135454; -.
DR   Orphanet; 101006; Autosomal recessive spastic paraplegia type 26.
DR   PharmGKB; PA28532; -.
DR   eggNOG; ENOG410IF61; Eukaryota.
DR   eggNOG; ENOG4111N56; LUCA.
DR   GeneTree; ENSGT00390000006679; -.
DR   HOGENOM; HOG000220853; -.
DR   HOVERGEN; HBG004812; -.
DR   InParanoid; Q00973; -.
DR   KO; K00725; -.
DR   OMA; FLRYNRL; -.
DR   OrthoDB; EOG091G04CW; -.
DR   PhylomeDB; Q00973; -.
DR   TreeFam; TF332297; -.
DR   BRENDA; 2.4.1.92; 2681.
DR   Reactome; R-HSA-1660662; Glycosphingolipid metabolism.
DR   GeneWiki; B4GALNT1; -.
DR   GenomeRNAi; 2583; -.
DR   PRO; PR:Q00973; -.
DR   Proteomes; UP000005640; Chromosome 12.
DR   Bgee; ENSG00000135454; -.
DR   CleanEx; HS_B4GALNT1; -.
DR   ExpressionAtlas; Q00973; baseline and differential.
DR   Genevisible; Q00973; HS.
DR   GO; GO:0000139; C:Golgi membrane; TAS:Reactome.
DR   GO; GO:0030173; C:integral component of Golgi membrane; IEA:InterPro.
DR   GO; GO:0016020; C:membrane; TAS:ProtInc.
DR   GO; GO:0005886; C:plasma membrane; IEA:Ensembl.
DR   GO; GO:0003947; F:(N-acetylneuraminyl)-galactosylglucosylceramide N-acetylgalactosaminyltransferase activity; IMP:UniProtKB.
DR   GO; GO:0005975; P:carbohydrate metabolic process; TAS:ProtInc.
DR   GO; GO:0001574; P:ganglioside biosynthetic process; IMP:UniProtKB.
DR   GO; GO:0006687; P:glycosphingolipid metabolic process; TAS:Reactome.
DR   GO; GO:0030259; P:lipid glycosylation; IEA:InterPro.
DR   GO; GO:0019915; P:lipid storage; IEA:Ensembl.
DR   GO; GO:0007283; P:spermatogenesis; IEA:Ensembl.
DR   Gene3D; 3.90.550.10; -; 1.
DR   InterPro; IPR001173; Glyco_trans_2-like.
DR   InterPro; IPR011143; GM2_synthase.
DR   InterPro; IPR029044; Nucleotide-diphossugar_trans.
DR   Pfam; PF00535; Glycos_transf_2; 1.
DR   PIRSF; PIRSF000474; GM2_GD2_synthase; 1.
DR   SUPFAM; SSF53448; SSF53448; 1.
PE   1: Evidence at protein level;
KW   Alternative splicing; Complete proteome; Disease mutation;
KW   Disulfide bond; Glycoprotein; Glycosyltransferase; Golgi apparatus;
KW   Hereditary spastic paraplegia; Lipid metabolism; Membrane;
KW   Neurodegeneration; Polymorphism; Reference proteome; Signal-anchor;
KW   Sphingolipid metabolism; Transferase; Transmembrane;
KW   Transmembrane helix.
FT   CHAIN         1    533       Beta-1,4 N-
FT                                acetylgalactosaminyltransferase 1.
FT                                /FTId=PRO_0000059100.
FT   TOPO_DOM      1      7       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM      8     25       Helical; Signal-anchor for type II
FT                                membrane protein. {ECO:0000255}.
FT   TOPO_DOM     26    533       Lumenal. {ECO:0000255}.
FT   CARBOHYD     79     79       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    179    179       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    274    274       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   DISULFID     80     80       Interchain (with C-412).
FT                                {ECO:0000269|PubMed:11018043}.
FT   DISULFID     82     82       Interchain (with C-529).
FT                                {ECO:0000269|PubMed:11018043}.
FT   DISULFID    412    412       Interchain (with C-80).
FT                                {ECO:0000269|PubMed:11018043}.
FT   DISULFID    429    476       {ECO:0000269|PubMed:11018043}.
FT   DISULFID    529    529       Interchain (with C-82).
FT                                {ECO:0000269|PubMed:11018043}.
FT   VAR_SEQ      74    128       Missing (in isoform 2).
FT                                {ECO:0000303|PubMed:14702039}.
FT                                /FTId=VSP_055039.
FT   VAR_SEQ     238    328       VRFSTEGHEAAFTIRIRHPPNPRLYPPGSLPQGAQYNISAL
FT                                VTIATKTFLRYDRLRALITSIRRFYPTVTVVIADDSDKPER
FT                                VSGPYVEHY -> GARPGWRDGQAGQTEKNQKGWSGQMAEG
FT                                MGGIWAMARAVQPHNGCFNWTSRARGRKGAFVHLGLEQARG
FT                                KPEPWVCLPFRPTVGGPRKRLV (in isoform 3).
FT                                {ECO:0000303|PubMed:15489334}.
FT                                /FTId=VSP_055040.
FT   VAR_SEQ     329    533       Missing (in isoform 3).
FT                                {ECO:0000303|PubMed:15489334}.
FT                                /FTId=VSP_055041.
FT   VARIANT      35     35       L -> V (in dbSNP:rs774896).
FT                                /FTId=VAR_012052.
FT   VARIANT     172    172       G -> R (in dbSNP:rs810205).
FT                                /FTId=VAR_012053.
FT   VARIANT     300    300       R -> C (in SPG26; dbSNP:rs756710480).
FT                                {ECO:0000269|PubMed:23746551}.
FT                                /FTId=VAR_070235.
FT   VARIANT     433    433       D -> A (in SPG26).
FT                                {ECO:0000269|PubMed:23746551}.
FT                                /FTId=VAR_070236.
FT   VARIANT     516    516       A -> V (in dbSNP:rs17454674).
FT                                /FTId=VAR_049237.
SQ   SEQUENCE   533 AA;  58882 MW;  533946E05E2A102B CRC64;
     MWLGRRALCA LVLLLACASL GLLYASTRDA PGLRLPLAPW APPQSPRRPE LPDLAPEPRY
     AHIPVRIKEQ VVGLLAWNNC SCESSGGGLP LPFQKQVRAI DLTKAFDPAE LRAASATREQ
     EFQAFLSRSQ SPADQLLIAP ANSPLQYPLQ GVEVQPLRSI LVPGLSLQAA SGQEVYQVNL
     TASLGTWDVA GEVTGVTLTG EGQADLTLVS PGLDQLNRQL QLVTYSSRSY QTNTADTVRF
     STEGHEAAFT IRIRHPPNPR LYPPGSLPQG AQYNISALVT IATKTFLRYD RLRALITSIR
     RFYPTVTVVI ADDSDKPERV SGPYVEHYLM PFGKGWFAGR NLAVSQVTTK YVLWVDDDFV
     FTARTRLERL VDVLERTPLD LVGGAVREIS GFATTYRQLL SVEPGAPGLG NCLRQRRGFH
     HELVGFPGCV VTDGVVNFFL ARTDKVREVG FDPRLSRVAH LEFFLDGLGS LRVGSCSDVV
     VDHASKLKLP WTSRDAGAET YARYRYPGSL DESQMAKHRL LFFKHRLQCM TSQ
//
